Skip to main content
TLRY
NASDAQ Life Sciences

Tilray Posts Record FY2026 Revenue of $915.5M and Sets FY2027 Adjusted EBITDA Guidance at $68M–$75M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.09
Mkt Cap
$483.612M
52W Low
$3.8
52W High
$23.2
52W Position info
7.6% above low
Off High info
82% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

TLRY is trading near its 52-week low of $3.8 (7.6% above the low).

Summary

Tilray's FY2026 10-K reports record revenue of $915.5M and record adjusted EBITDA of $61.1M, with FY2027 adjusted EBITDA guidance of $68M–$75M. The company completed the BrewDog and Lyphe acquisitions, transforming its beverage and medical cannabis platforms.


Key Events · Earnings and Guidance · TLRY

  • Record FY2026 Revenue and EBITDA

    Revenue reached $915.5M, up 11% YoY, driven by 34% growth in international cannabis and the BrewDog acquisition. Adjusted EBITDA hit a record $61.1M, up 11%.

  • FY2027 Adjusted EBITDA Guidance

    Management guided FY2027 adjusted EBITDA to $68M–$75M, implying 11%–23% growth at the midpoint, signaling confidence in continued margin expansion.

  • Transformative BrewDog Acquisition

    The BrewDog acquisition, completed in Q4, added a global craft beer platform with pro forma annual revenue of ~$190M, expanding Tilray's beverage segment internationally.

  • Strong Liquidity Position

    Cash, restricted cash, and marketable securities totaled $234.6M as of May 31, 2026, providing ample runway for operations and strategic initiatives.


Analysis · TLRY · Life Sciences

Tilray's 10-K marks a definitive turnaround: revenue climbed 11% to a record $915.5 million, while adjusted EBITDA also reached a new high of $61.1 million. Looking ahead, management guided FY2027 adjusted EBITDA to $68–$75 million, underscoring its confidence in sustained profitability. The balance sheet carries $234.6 million in cash and marketable securities, and the auditor delivered a clean opinion with no going concern warning. The filing also details two transformative deals—the BrewDog acquisition, which added a global craft beer platform, and the Lyphe acquisition, expanding the company's medical cannabis footprint in the UK. With 136.2 million shares outstanding and an active ATM program, dilution remains a risk, but the dominant story is the strong operational performance and upbeat guidance.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1410 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, TLRY was trading at $4.09 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $483.6M. The 52-week trading range was $3.80 to $23.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

TLRY - Latest Insights

TLRY
Nov 02, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.51
Real-time Price: $2.76 info
Change: +$0.2525 (+10%) info
Market Cap: $415.283M info
TLRY
Oct 29, 2026, 8:18 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.70
Real-time Price: $2.76 info
Change: +$0.063 (+2%) info
Market Cap: $415.283M info
TLRY
Oct 12, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.53
Real-time Price: $2.76 info
Change: -$0.7635 (-22%) info
Market Cap: $415.283M info
TLRY
Oct 08, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.61
Real-time Price: $2.76 info
Change: -$0.8515 (-24%) info
Market Cap: $415.283M info
TLRY
Oct 08, 2026, 7:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.70
Real-time Price: $2.76 info
Change: -$0.9382 (-25%) info
Market Cap: $415.283M info